Delivery Order SPE2DB20D3101-SPE2DB22FH5T8

Award Date 1/24/22
Potential Completion Date 1/25/22
Potential Value $1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Humalog 100 unit/mL KwikPen insulin pens to the Defense Logistics Agency (DLA). The $1,119.24 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 18, 2022, with a completion date of February 22, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
This federal contract award is for the delivery of Humalog 100 Unit/ML Kwikpen 3ML, a prescription insulin product, to the Defense Logistics Agency (DLA). The $3,072.96 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 3, 2023, with an ultimate completion date of April 4, 2023. The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Humalog 100 Unit/ML Kwikpen 3ML, a prescription medication, to the Defense Logistics Agency (DLA). The $1,057.28 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021, with a completion date of September 27, 2021. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Humalog 100 Unit/mL KwikPen 3mL to the Defense Logistics Agency (DLA). The $1,957.48 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the delivery of Humalog 100 unit/ml KwikPen 3ml insulin products to the Defense Logistics Agency (DLA). The $6,062.67 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 25, 2022, with a completion date of April 26, 2022. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award is for the delivery of Humalog 100 Unit/mL Kwikpen (3mL) pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,289.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with no set-aside designation. The contract has a completion date of November 14, 2023 and was awarded on November 13, 2023. AmerisourceBergen holds a significant...
This federal contract award, valued at $1,570.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Humalog 100 unit/mL KwikPen 3mL, a brand-name insulin product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a brand-name insulin product, to the Defense Logistics Agency (DLA). The contract is a delivery order valued at $2,048.64 with a firm fixed price and an ultimate completion date of October 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award is for the delivery of Humalog 100 unit/ml KwikPen 3ml, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The $2,146.15 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 12, 2023, with a completion date of July 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.32, is for the delivery of Humalog 100 Unit/mL Kwikpen 3mL, a type of insulin medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 31, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FH5T8
    Delivery Order

This federal contract award is for the delivery of Humalog 100 Unit/mL Kwikpen 3mL, a brand-name insulin medication, to the Defense Logistics Agency (DLA). The $1,025.97 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2022, with a completion date of January 25, 2022.

The contract is a delivery order placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to efficiently deliver essential pharmaceutical and medical commodities to multiple federal agencies, including the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 2/27/25, 11:10 AM